Yukun Wang

No. 238 Jiefang Road
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Extracellular histone H3 induces METosis in acute liver failure by regulating the NRF2/HO-1/NQO1 pathway-mediated oxidative stress.

Extracellular histone H3 induces METosis in acute liver failure by regulating the NRF2/HO-1/NQO1 pathway-mediated oxidative stress.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: July 02, 2025

Extracellular histone H3 induces macrophage inflammation in acute liver failure via HDAC2 activation and PKM2 subcellular relocalization.

Extracellular histone H3 induces macrophage inflammation in acute liver failure via HDAC2 activation and PKM2 subcellular relocalization.

Journal: Cellular signalling

Published: May 19, 2025

The FMO3/TMAO/HSP90β axis aggravates MAFLD by disrupting mitochondrial protein homeostasis.

The FMO3/TMAO/HSP90β axis aggravates MAFLD by disrupting mitochondrial protein homeostasis.

Journal: Cellular signalling

Published: February 27, 2025

IDH1/MDH1 deacetylation activates the cGAS-STING pathway by promoting NETosis in acute liver failure.

IDH1/MDH1 deacetylation activates the cGAS-STING pathway by promoting NETosis in acute liver failure.

Journal: International immunopharmacology

Published: January 20, 2025

Targeting the HDAC6/Hint2/MICU1 axis to ameliorate acute liver failure via inhibiting NETosis.

Targeting the HDAC6/Hint2/MICU1 axis to ameliorate acute liver failure via inhibiting NETosis.

Journal: Life sciences

Published: December 02, 2024

Role of malate dehydrogenase 1 and isocitrate dehydrogenase 1 and their posttranslational modifications in diseases.

Role of malate dehydrogenase 1 and isocitrate dehydrogenase 1 and their posttranslational modifications in diseases.

Journal: Biochemical and biophysical research communications

Published: November 12, 2024

The Role of Extracellular Histones in Disease Progression: A Potential Therapeutic Target for Disease Modulation.

The Role of Extracellular Histones in Disease Progression: A Potential Therapeutic Target for Disease Modulation.

Journal: Frontiers in bioscience (Landmark edition)

Published: October 30, 2024

MPO-DNA Complexes and cf-DNA in Patients with Sepsis and Their Clinical Value.

MPO-DNA Complexes and cf-DNA in Patients with Sepsis and Their Clinical Value.

Journal: Biomedicines

Published: September 09, 2024

IDH1/MDH1 deacetylation promotes NETosis by regulating OPA1 and autophagy.

IDH1/MDH1 deacetylation promotes NETosis by regulating OPA1 and autophagy.

Journal: International immunopharmacology

Published: August 15, 2024

Metabolic Dysregulation and Metabolite Imbalances in Acute-on-chronic Liver Failure: Impact on Immune Status.

Metabolic Dysregulation and Metabolite Imbalances in Acute-on-chronic Liver Failure: Impact on Immune Status.

Journal: Journal of clinical and translational hepatology

Published: June 18, 2024

Correction: Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death.

Correction: Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death.

Journal: Journal of inflammation (London, England)

Published: June 12, 2024

Deacetylated MDH1 and IDH1 aggravates PANoptosis in acute liver failure through endoplasmic reticulum stress signaling.

Deacetylated MDH1 and IDH1 aggravates PANoptosis in acute liver failure through endoplasmic reticulum stress signaling.

Journal: Cell death discovery

Published: April 27, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026